Gladius Therapeutics
Philadelphia, US · Founded 2023
Healthtech
Founders & leadership
MS
Michael SeidenExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements▶$300KraisedAug 2023 · 4 investors · Other Health CareRule 506(b)
▶$300KraisedAug 2023 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael SeidenExecutive Officer, Director, Promoter
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.